Clough Capital Partners L P Ab Cellera Biologics Inc. Transaction History

Clough Capital Partners L P

  • $924 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$12.99 - $17.73 $12.6 Million - $17.2 Million
-971,297 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$14.85 - $21.34 $4.05 Million - $5.82 Million
272,497 Added 38.99%
971,297 $19.5 Million
Q2 2021

Aug 16, 2021
BUY
$20.19 - $34.17 $4.53 Million - $7.66 Million
224,316 Added 47.28%
698,800 $15.4 Million
Q1 2021

May 17, 2021
BUY
$23.29 - $53.2 $11.1 Million - $25.2 Million
474,484 New
474,484 $16.1 Million

Others Institutions Holding ABCL

# of Institutions
154
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $864M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email